Amomed Pharma GmbH
Amomed Pharma GmbH
Contact:
Beatrix Mick Schrempf
Phone: +43 1 545 01 13-26
E-Mail: b.mick-schrempf@amomed.com
KEYWORDS:
  • medical drugs
  • health
  • medicine
Download Photos
Amomed Pharma GmbH (100 releases)

A new therapeutic option for septic shock has now been approved for and is available in 26 European countries. Sepsis affects 27-30 million people and leads to eight million deaths worldwide every year. Septic shock is caused by a generalized bacterial infection and is associated with higher morbidity and mortality as well as extended invalidity. Most importantly, sepsis has negative effects on the cardiovascular system. Blood pressure drops, consciousness is clouded, the heart rate and respiratory rate increase. Worsened macro and micro-circulation leads to impaired blood flow to organs and ultimately to organ damage. [more]

Congresso de Neurologia em Lisboa dedicado à Neurogenética
2018-06-15, ptp20180615025 Health/Medicine, Science/Technology
Neurology congress in Lisbon devoted to neurogenetics
2018-06-15, ptp20180615018 Health/Medicine, Science/Technology
World Brain Day 2018 devoted to the impact of air pollution on brain health
2018-05-22, ptp20180522020 Health/Medicine, Sport/Events
Neurological diseases major challenge for health systems
2017-09-28, ptp20170928026 Health/Medicine, Science/Technology
Blood fats play key role in peripheral neuropathy for patients with type 2 diabetes
2017-09-21, ptp20170921008 Health/Medicine, Science/Technology
School-based instruction on strokes can save lives and help to prevent lasting disabilities
2017-09-20, ptp20170920013 Health/Medicine, Science/Technology
New dementia test enables diagnosis in 15 minutes
2017-09-20, ptp20170920011 Health/Medicine, Science/Technology

1 2 3 4 5 6 7 8 9 10 Next »